Icon Wealth Advisors LLC Has $682,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Icon Wealth Advisors LLC cut its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 83.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,490 shares of the company's stock after selling 17,648 shares during the period. Icon Wealth Advisors LLC's holdings in Zoetis were worth $682,000 as of its most recent filing with the SEC.

Several other institutional investors also recently added to or reduced their stakes in ZTS. Mizuho Securities USA LLC increased its position in shares of Zoetis by 13,726.9% during the third quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company's stock valued at $950,524,000 after purchasing an additional 4,829,815 shares during the period. Sarasin & Partners LLP lifted its holdings in shares of Zoetis by 546.3% during the 2nd quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company's stock worth $390,682,000 after acquiring an additional 1,904,899 shares during the period. Swedbank AB acquired a new stake in shares of Zoetis during the 1st quarter valued at about $210,815,000. International Assets Investment Management LLC raised its stake in Zoetis by 41,235.7% during the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company's stock worth $183,652,000 after acquiring an additional 937,700 shares in the last quarter. Finally, Marshall Wace LLP grew its stake in Zoetis by 7,608.6% during the second quarter. Marshall Wace LLP now owns 835,684 shares of the company's stock worth $144,874,000 after buying an additional 824,843 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on ZTS shares. JPMorgan Chase & Co. lifted their target price on Zoetis from $225.00 to $230.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Piper Sandler lifted their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 14th. BTIG Research upped their price objective on shares of Zoetis from $220.00 to $225.00 and gave the company a "buy" rating in a research report on Monday, August 12th. Argus upgraded Zoetis to a "strong-buy" rating in a report on Friday, August 9th. Finally, Stifel Nicolaus increased their price target on Zoetis from $200.00 to $210.00 and gave the stock a "buy" rating in a report on Wednesday, September 18th. Ten analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $221.44.

Zoetis Stock Performance

Zoetis stock traded up $0.25 during midday trading on Friday, reaching $176.96. 1,854,574 shares of the company's stock were exchanged, compared to its average volume of 2,832,691. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. The stock's 50-day simple moving average is $185.62 and its 200 day simple moving average is $180.61. The firm has a market cap of $79.84 billion, a price-to-earnings ratio of 33.26, a P/E/G ratio of 2.71 and a beta of 0.90. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company's quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.36 earnings per share. On average, analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.98%. Zoetis's dividend payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.